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SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comﬂow velocity, even in stenoses selected on the basis of anatomy. This additive pre-
dictive value is retained even in intermediate stenoses when anatomical factors are
particularly unhelpful. This supports the use of physiology in a wide range of stenoses
when the aim of PCI is improve ﬂow.
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Background: Fractional Flow Reserve (FFR) measurements have been limited by the
difﬁculty of maneuvering 0.014 inch diameter pressure wires. The RXi system
(ACIST Medical Systems, Eden Prairie, MN) is a new FFR technology utilizing a
monorail ultrathin microcatheter with an optical pressure sensor located close to the
distal tip of the catheter. FFR measured with the RXi system has been shown to be
correlated closely with the Pressurewire (St. Jude Medical, St. Paul, MN). A pro-
spective, observational registry was set up to collect real-world clinical experience of
the RXi system.
Methods: The ADVANCE-EU study enrolled 60 subjects at 7 centers in France,
Germany, Italy and Spain. Patients 21 years of age or older provided informed consent
and were enrolled in the registry following use of the Navvus catheter to guide PCI
strategy. Using physician preferred guidewires, FFR measurement and interventional
treatment was completed per each centers standard care. Procedural success was
deﬁned as the ability of the Navvus catheter to acquire FFR measurement without
adverse device effect or device malfunction.
Results: Preliminary analysis was obtained in the ﬁrst 45 patients (57 lesions) already
monitored, mean age 69 yrs, diabetes mellitus 31%, stable angina 51%, radial
approach 58% of cases. The vessel was moderately or severely tortuous in 36% and 11
% of cases respectively and moderately or severely calciﬁed in 54 and 16% of cases
respectively. The Navvus Catheter was used without adverse device effect or device
malfunction in all cases. The lesions analyzed were successfully crossed with the
Navvus catheter in 93% of cases. Jailed side branches and moderate to severely
calciﬁed lesions that were not initially crossed by the Navvus catheter were either left
untreated or underwent PCI followed by FFR measurement with the Navvus catheter.
Conclusions: The preliminary results of this real world prospective registry show that
the RXi system can be used successfully to assess FFR in relatively complex anatomy
and lesions. This new device may simplify FFR measurements by allowing the use of
standard coronary guidewires to deliver an intracoronary pressure sensor. Final results
will be presented at the meeting.
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Background: Development of advanced quantitative models might aid establishing
the relation between bifurcation anatomy and fractional ﬂow reserve (FFR). The aim
of this study was to present for the ﬁrst time a new bifurcation model for quantiﬁcation
of stenotic severity in the entire bifurcation lesion. The diagnostic performance of this
model empowered by 3-dimensional quantitative coronary angiography in predicting
the functional signiﬁcance of obstructive bifurcation stenoses was evaluated using
FFR as reference standard.
Methods: Patients who had been admitted in ﬁve European hospitals for various
studies involving FFR measurement in bifurcation lesions were randomly selected and
analyzed by a core laboratory. Different diameter models including Murray, Finet, and
HK models were implemented in the proposed bifurcation model for optimization of
reference diameter functions, resulting in different degrees of stenosis. The conven-
tional straight, i.e., single branch, model was included to compare with the bifurcation
model.
Results: Seventy-eight bifurcation lesions in 73 patients were analyzed. In 51 (65%)
bifurcations FFR was measured in the main vessel. A total of 34 (43.6%) interrogated
vessels had an FFR 0.80. Average minimum lumen diameter was 1.270.29 mm.B96 JACC Vol 64/11/Suppl B j SeptemberThe diameter stenosis optimized by the HK diameter model had the highest correlation
with FFR (r ¼ -0.50, p < 0.001), as compared to the Finet model (r ¼ -0.49, p <
0.001), the Murray model (r ¼ -0.41, p < 0.001), and the straight model (r ¼ -0.23, p
< 0.001). The AUC for predicting FFR  0.80 was signiﬁcantly higher by the
bifurcation model than the straight model, being 0.72 (95% CI: 0.61; 0.82) versus 0.60
(95% CI: 0.49; 0.71), p ¼ 0.001. Applying 50% diameter stenosis assessed by the
bifurcation model for predicting FFR 0.80 resulted in 23 true positives, 27 true
negatives, 17 false positives, and 11 false negatives.
Conclusions: The new bifurcation model provides comprehensive assessment of
bifurcation anatomy. Compared to the straight model, identiﬁcation of lesions with
preserved FFR values in obstructive bifurcation stenosis was improved. However,
Accuracy was limited by use of pure anatomy without integration of coronary ﬂow.
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Background: The prognostic value of post-stent FFR has not been clearly deﬁned in
patients with DES implantation. We sought to evaluate the association between
fractional ﬂow reserve (FFR) and clinical outcomes after drug eluting stent (DES)
implantation with intravascular ultrasound (IVUS) assistance.
Methods: One-hundred and ﬁfteen lesions (107 patients) with FFR measurement after
DES implantation assisted by IVUS were enrolled. Post-stent angiographic and IVUS
parameters were compared with FFR values. Clinical outcomes were assessed by
target vessel failure (TVF) deﬁned as a composite of target vessel revascularization,
death or non-fatal myocardial infarction attributed to the target vessel.
Results: Mean post-stent FFR was 0.920.04. Minimal stent area by IVUS had a
positive correlation with post-stent FFR (r¼0.36, p< 0.01). Post-stent FFR 0.89 was
a physiologic cut-off value for 1-year TVF-free survival. Best cut-off value of minimal
stent area to deﬁne post-stent FFR 0.89 was >5.4mm2, and its sensitivity and
speciﬁcity were 63.2% and 90.0%, respectively. During a 3 year follow-up, lesions
with post-stent FFR 0.89 had a better TVF-free survival rate than those with post-
stent FFR < 0.89 (89.3% vs. 61.1%, p¼0.03). By Cox-regression analysis, post-stent
FFR 0.89 was an independent predictor for TVF-free survival (Exp(B) ¼7.8, 95%
CI¼1.3-46.9, p¼0.03).Conclusions: Post-stent FFR can be a useful predictor for long-term clinical outcomes
after DES implantation and relevant to IVUS minimal stent area.
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Background: Invasive Fractional Flow Reserve (FFR) is the gold standard to identify
hemodynamically relevant coronary stenoses. We developed and evaluated a new
approach to determine lesion-speciﬁc FFR based on coronary anatomy as visualized
by invasive coronary angiography.
Methods: In 52 lesions (48 individuals), Invasive FFRinvasive was determined using
a pressure wire during adenosine-induced vasodilation. Coronary angiograms from
two views were acquired under resting conditions. These were processed ofﬂine with
syngo IZ3D (SiemensHealthcare Sector) to obtain a 3-dimensional model of the13–17, 2014 j TCT Abstracts/FFR and Physiologic Lesion Assessment
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMcoronary tree. A novel prototypic computational model including an estimation of
personalized boundary conditions was used for ﬂow calculation to derive FFRangio
based on angiographic anatomy, heart rate and blood pressure.
Results: Of 52 coronary lesions (LAD: 38, LCX: 6, RCA: 8), 12 were hemody-
namically signiﬁcant (FFRinvasive < 0.80). FFRangio identiﬁed these lesions with an
accuracy of 90%, sensitivity of 67%, speciﬁcity of 98%, positive predictive value of
89%, and negative predictive value of 91%. Correlation between FFRinvasive (mean:
0.84  0.12) and FFRangio (mean: 0.86 0.09) was r ¼ 0.82 (see ﬁg. 1).
Conclusions: Model-based determination of coronary FFR based on invasive angi-
ography has a high diagnostic accuracy when compared to invasive FFR. Further
research will be performed to reﬁne models and obtain further veriﬁcation of the
method.TCT-335
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Background: Coronary ﬂow reserve is deﬁned as the ratio of hyperaemic to baseline
blood ﬂow and is concomitantly affected by both epicardial patency and microvas-
cular function. Recent insights in the prognostic value of the coronary microcircula-
tion in ischemic heart disease revived the interest of clinicians in CFR. Coronary
pressure derived CFR (CFRpres) was introduced aiming to alleviate contemporary
practical limitations. This simpliﬁed model neglects the effects of stenosis geometry
on ﬂow impediment, raising concerns on its validity. We sought to validate CFRpres
against ﬂow derived CFRﬂow determined by means of Doppler ﬂow velocity and
thermodulution in a large cohort of coronary stenoses of intermediate severity.
Methods: We evaluated the CFR in 419 stenoses from 322 patients with coronary
artery disease. In 299 coronary stenoses CFRﬂow was evaluated by means ﬂow ve-
locity measurements, calculated as the ratio of hyperaemic average peak ﬂow velocity
(APV) to APV during basal conditions and CFRpres as indicated above. In addition,
in 120 coronary stenoses CFRﬂow was determined by means of the thermodilution,
deﬁned as the ratio of hyperaemic to baseline mean transit time. CFRpres was
calculated as the square root of the pressure-drop across the stenosis during hyper-
aemia divided by the square root of the pressure-drop at baseline.
Results: CFRﬂow was higher than CFRpres [median 2.17 (1.56-2.7) vs 1.48 (1.23-
1.83); p< 0.001]. There was a moderate overall linear correlation between CFRﬂow
and CFRpres (p< 0.001; R2¼0.09). Bland Altman analyses showed a mean bias of
-0.57, with a proportional error of -0.41 (p < 0.001) and signiﬁcant heteroscedasticity
as well as by constant [A¼ -0.52 (95% CI: -0.37 to -0.65)] and proportional [B¼0.49
(0.41 to 0.58)] differences.
Conclusions: CFRpres systematically underestimates CFRﬂow values measured by
contemporary invasive methods, and its magnitude of deviation is related to the
magnitude of underlying CFRﬂow. Hence CFRpres cannot be used as an alternative to
CFRﬂow.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/FFTCT-336
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Background: Fractional ﬂow reserve (FFR) has been proposed as the gold standard to
assess functional severity of coronary artery stenosis and to stratify which lesions
should be subjected to coronary intervention (PCI). Our aim was to determine the
safety of using FFR as a decision-making tool for deferral or performance of PCI,
based on data from published studies.
Methods: Systematic review by independent researchers was performed in
PubMed and EMBASE including papers indexed until October 11th 2013 that used
FFR (0.75 or 0.80) to determine in which lesions PCI should be performed or
deferred. Outcomes of interest were death, myocardial infarction (AMI) and new
revascularization (RV). Comprehensive Meta Analysis was used to pool study
results and for meta-regression.
Results: After peer review, 60 abstracts remained and 19 papers (12 observational
studies and 7 randomized-controlled trials) were included for analysis, totaling 3,097
patients (3,796 lesions). Nine papers had two arms (PCI and Defer) and 10 had only
the Defer arm; FFR cut-off was 0.75 in 15 studies, and 0.80 in 4. Weighted mean
follow-up time was 21.2 months (6.9 to 53). In indirect comparisons, PCI and Defer
groups had similar death: 2.2% (CI95% 0.9-5.1%, I2¼72.7) x 2.0% (1.1-3.5%,
I2¼40.5), p¼0.86, and AMI rates: 1.9% (0.8-4.0%, I2¼0) x 1.9% (1.1-3.1%,
I2¼49.8), p¼1.00. RV rates were higher in the PCI group: 14.0% (8.0-23.2%,
I2¼87.8) x 4.4% (8.8-6.9%, I2¼58.9), p¼0.002. Direct comparisons, including two-
arm trials, also showed no differences in death: OR ¼ 1.86 (0.81–4.27, I2¼11.5;
p¼0.14) and AMI rates: OR ¼ 0.75 (0.21–2.69, I2¼47.1; p¼0.66); RV rates were
again higher in the PCI group: OR ¼ 3.10 (1.25–7.70, I2¼72.2; p¼0.015). Meta-
regression suggests inﬂuence of the proportion men on the RV rates (b¼0,058,
p¼0,026). No other co-factors (age, hypertension, diabetes, FFR cut-off) inﬂuenced
the outcomes.
Conclusions: Based on pooled data, FFR seems to be a safe and useful tool to
determine lesions to be treated. Higher RV rates were observed in the PCI groups,
speculatively related to restenosis. This data, however, should be parsimoniously
interpreted, given the considerable heterogeneity of the studies published so far.
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Background: It has been shown that index of microcirculatory resistance (IMR) in
infarct-related artery is an predictor of infarct size and recovery of left ventricular
function in patients with ST-segment elevation myocardial infarction (STEMI)
treated by primary percutaneous coronary intervention (PCI). However, micro-
circulatory resistance in non-infarct-related arteries remains unknown in patients
with STEMI.
Methods: In order to quantitatively assess microcirculatory resistance in infarct and
non-infarct territories, we determined IMR in infarct-realted and non-infarct-related
coronary arteries with no critical stenosis (diameter stenosis < 70% in non-infarct-
related arteries) in 70 patients with the ﬁrst STEMI treated with primary PCI. Coro-
nary wedge pressure was measured in infarct-related artery and used for the calcu-
lation of corrected IMR.
Results: The IMR in infarct-realted artery was signiﬁcantly increased as compared
with IMR in non-infarct- related arteries: median 32.5 U (range 7.4 to 162.1) vs. 20.3
U (range 7.9 to 49.9; P< 0.001) in an adjacent vessel and 32.5 vs. 22.6 (range 5.9 to
105.1; P¼0.0022) in artery giving collateral blood supply to the infarct-related artery.
Corrected IMR was also increased compared to IMR in non-infarct-related arteries:
29.9 U (range 10.3 to 112.2) vs. 20.3 U, P< 0.001 and 29.9 vs. 22.6 U, P¼0.0047.
The IMR values in the adjacent vessel and vessel giving collateral blood supply to
infarct-related artery were similar (20.3 vs 22.6 U, P¼0.32).
Conclusions: Microcirculatory resistance is elevated in the teritory of infarct-
related artery as compared with non-infarct-related arteries in patients with STEMI.
There is no difference in the microcirculatory resistance between vessel adjacent to
infarct-related artery and vessel giving collateral blood supply to infarct-related
artery.
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